Bimekizumab Approved in Europe for Psoriasis Treatment Bimekizumab Approved in Europe for Psoriasis Treatment
In the United States, the US Food and Drug Administration is expected to make a decision on approval of bimekizumab for treating psoriasis on October 15.Medscape Medical News
Source: Medscape Rheumatology Headlines - Category: Rheumatology Tags: Dermatology News Source Type: news
More News: Dermatology | Food and Drug Administration (FDA) | Psoriasis | Rheumatology | Skin | USA Health